Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Tier 3 reports for ' ROPIVACAINE HYDROCHLORIDE' and 'solution'

Tier 3 Drug Shortages

4 reports found

Brand name	Company Name	Date Updated	Strength(s)	Status	Report ID
NAROPIN	ASPEN PHARMACARE CANADA INC.	2026-01-15	10MG	Actual shortage	271416
NAROPIN	ASPEN PHARMACARE CANADA INC.	2026-01-05	10MG	Actual shortage	270404
ROPIVACAINE HYDROCHLORIDE INJECTION, USP	FRESENIUS KABI CANADA LTD	2025-12-09	10MG	Resolved	257455
ROPIVACAINE HYDROCHLORIDE INJECTION, USP	FRESENIUS KABI CANADA LTD	2025-12-05	2MG	Resolved	268276

1

Showing 1 to 4 of 4

Tier 3 Drug Discontinuations

0 reports found

Brand name	Company Name	Date Updated	Strength(s)	Status	Report ID

1

Showing 1 to 0 of 0